BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sadhukha T, Layek B, Prabha S. Incorporation of lipolysis in monolayer permeability studies of lipid-based oral drug delivery systems. Drug Deliv and Transl Res 2018;8:375-86. [DOI: 10.1007/s13346-017-0383-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Xu Y, Michalowski CB, Beloqui A. Advances in lipid carriers for drug delivery to the gastrointestinal tract. Current Opinion in Colloid & Interface Science 2021;52:101414. [DOI: 10.1016/j.cocis.2020.101414] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Ashkar A, Sosnik A, Davidovich-Pinhas M. Structured edible lipid-based particle systems for oral drug-delivery. Biotechnol Adv 2021;:107789. [PMID: 34186162 DOI: 10.1016/j.biotechadv.2021.107789] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Agrahari V. Novel drug delivery systems, devices, and fabrication methods. Drug Deliv Transl Res 2018;8:303-6. [PMID: 29204923 DOI: 10.1007/s13346-017-0459-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Ding D, Sun B, Cui W, Chen Q, Zhang X, Zhang H, He Z, Sun J, Luo C. Integration of phospholipid-drug complex into self-nanoemulsifying drug delivery system to facilitate oral delivery of paclitaxel. Asian J Pharm Sci 2019;14:552-8. [PMID: 32104482 DOI: 10.1016/j.ajps.2018.10.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
5 Keemink J, Bergström CAS. Caco-2 Cell Conditions Enabling Studies of Drug Absorption from Digestible Lipid-Based Formulations. Pharm Res 2018;35:74. [PMID: 29484506 DOI: 10.1007/s11095-017-2327-8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 7.8] [Reference Citation Analysis]
6 Joyce P, Dening TJ, Meola TR, Gustafsson H, Kovalainen M, Prestidge CA. Nanostructured clay particles supplement orlistat action in inhibiting lipid digestion: An in vitro evaluation for the treatment of obesity. European Journal of Pharmaceutical Sciences 2019;135:1-11. [DOI: 10.1016/j.ejps.2019.05.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Gasa-falcon A, Arranz E, Odriozola-serrano I, Martín-belloso O, Giblin L. Delivery of β-carotene to the in vitro intestinal barrier using nanoemulsions with lecithin or sodium caseinate as emulsifiers. LWT 2021;135:110059. [DOI: 10.1016/j.lwt.2020.110059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
8 Berthelsen R, Klitgaard M, Rades T, Müllertz A. In vitro digestion models to evaluate lipid based drug delivery systems; present status and current trends. Adv Drug Deliv Rev 2019;142:35-49. [PMID: 31265861 DOI: 10.1016/j.addr.2019.06.010] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 17.3] [Reference Citation Analysis]
9 Jakobsen S, Gaenaelle Gé L, Pedersen M, Griffin BT, Holm R, Uhd Nielsen C. P-glycoprotein-mediated transport in a mucus-supplemented Caco-2 cell model in the presence of different surfactants. Int J Pharm 2022;:121885. [PMID: 35690306 DOI: 10.1016/j.ijpharm.2022.121885] [Reference Citation Analysis]
10 Maher S, Brayden DJ. Formulation strategies to improve the efficacy of intestinal permeation enhancers. Adv Drug Deliv Rev 2021;177:113925. [PMID: 34418495 DOI: 10.1016/j.addr.2021.113925] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
11 Layek B, Rahman Nirzhor SS, Rathi S, Kandimalla KK, Wiedmann TS, Prabha S. Design, Development, and Characterization of Imiquimod-Loaded Chitosan Films for Topical Delivery. AAPS PharmSciTech 2019;20:58. [PMID: 30623265 DOI: 10.1208/s12249-018-1288-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
12 Heade J, Maher S, Bleiel SB, Brayden DJ. Labrasol® and Salts of Medium-Chain Fatty Acids Can Be Combined in Low Concentrations to Increase the Permeability of a Macromolecule Marker Across Isolated Rat Intestinal Mucosae. J Pharm Sci 2018;107:1648-55. [PMID: 29462634 DOI: 10.1016/j.xphs.2018.02.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
13 Choi J, Cho NH, Kim D, Park J. Comparison of paclitaxel solid dispersion and polymeric micelles for improved oral bioavailability and in vitro anti-cancer effects. Materials Science and Engineering: C 2019;100:247-59. [DOI: 10.1016/j.msec.2019.03.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
14 Pham AC, Clulow AJ, Boyd BJ. Formation of Self-Assembled Mesophases During Lipid Digestion. Front Cell Dev Biol 2021;9:657886. [PMID: 34178984 DOI: 10.3389/fcell.2021.657886] [Reference Citation Analysis]
15 Gonçalves RFS, Martins JT, Abrunhosa L, Baixinho J, Matias AA, Vicente AA, Pinheiro AC. Lipid-based nanostructures as a strategy to enhance curcumin bioaccessibility: Behavior under digestion and cytotoxicity assessment. Food Res Int 2021;143:110278. [PMID: 33992378 DOI: 10.1016/j.foodres.2021.110278] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Bolaños Quiñones VA, Zhu H, Solovev AA, Mei Y, Gracias DH. Origami Biosystems: 3D Assembly Methods for Biomedical Applications. Adv Biosys 2018;2:1800230. [DOI: 10.1002/adbi.201800230] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
17 Suys EJA, Brundel DHS, Chalmers DK, Pouton CW, Porter CJH. Interaction with biliary and pancreatic fluids drives supersaturation and drug absorption from lipid-based formulations of low (saquinavir) and high (fenofibrate) permeability poorly soluble drugs. J Control Release 2021;331:45-61. [PMID: 33450318 DOI: 10.1016/j.jconrel.2021.01.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Keemink J, Hedge OJ, Bianco V, Hubert M, Bergström CAS. Comparison of Cellular Monolayers and an Artificial Membrane as Absorptive Membranes in the in vitro Lipolysis-permeation Assay. J Pharm Sci 2021:S0022-3549(21)00478-0. [PMID: 34516987 DOI: 10.1016/j.xphs.2021.09.009] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Gasa-Falcon A, Odriozola-Serrano I, Oms-Oliu G, Martín-Belloso O. Nanostructured Lipid-Based Delivery Systems as a Strategy to Increase Functionality of Bioactive Compounds. Foods 2020;9:E325. [PMID: 32168809 DOI: 10.3390/foods9030325] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
20 Maher S, Brayden DJ, Casettari L, Illum L. Application of Permeation Enhancers in Oral Delivery of Macromolecules: An Update. Pharmaceutics 2019;11:E41. [PMID: 30669434 DOI: 10.3390/pharmaceutics11010041] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 17.7] [Reference Citation Analysis]